Digital Cognitive Behavioral Therapy for Insomnia in China

June 13, 2022 updated by: Peking University

The Feasibility and Effectiveness of Digital Cognitive Behavioral Therapy for Insomnia in China: A Pilot Randomized Controlled Trial

Digital cognitive behavioral therapy for insomnia (dCBT-i) is found to be effective but is rarely used in China. Hence, the investigators developed an automated Chinese dCBT-i program and examined its feasibility, acceptability, and preliminary effectiveness in individuals with insomnia symptoms.

Study Overview

Study Type

Interventional

Enrollment (Actual)

217

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing
      • Beijing, Beijing, China
        • Peking University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • were aged 18 or older;
  • had a positive screening result for chronic insomnia, i.e., a score of 16 or lower on the Sleep Condition Indicator (SCI);
  • had stable access to the internet via a smartphone.

Exclusion Criteria:

  • additional sleeping conditions except for insomnia (such as restless legs syndrome and sleep apnea);
  • psychosis or mania;
  • serious physical health concerns necessitating surgery or with prognosis <6 months;
  • undergoing medical or psychological treatment for insomnia with a health professional;
  • habitual night shift, evening, or rotating shift-workers.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: dCBT-i
The dCBT-i group received the whole intervention
Cognitive behavioral therapy for insomnia (CBT-i) has been showed to be effective in reducing insomnia symptoms and insomnia-related symptoms, including sleepiness, dysfunctional beliefs and attitudes about sleep, anxiety and depressive symptoms
Active Comparator: Sleep Hygiene Education (SHE)
The SHE group received sleep hygiene education delivered in text form, and the same intervention as the dCBT-i group did after four weeks.
Cognitive behavioral therapy for insomnia (CBT-i) has been showed to be effective in reducing insomnia symptoms and insomnia-related symptoms, including sleepiness, dysfunctional beliefs and attitudes about sleep, anxiety and depressive symptoms
The SHE group received sleep hygiene education delivered in text form, and the same intervention as the dCBT-i group did after four weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
sleep diary
Time Frame: week 4
recording one's sleep efficiency, total sleep time, sleep onset latency, wakefulness after sleep onset, and subjective sleep quality
week 4
Sleep Condition Indicator-8
Time Frame: week 4
Sleep Condition Indicator-8 is an 8-item scale validated against Diagnostic and Statistical Manual-5 criteria, concerning sleep quality and daytime personal functioning. It scores between 0 to 32, with higher scores meaning better sleep.
week 4

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the Insomnia Severity Index 7-item version
Time Frame: week 4
It scores between 0 to 28, with higher scores meaning more severe insomnia.
week 4
the Dysfunctional Beliefs and Attitudes about Sleep Scale 16-item version
Time Frame: week 4
It scores between 16 to 80, with higher scores meaning more dysfunctional beliefs.
week 4
the Epworth Sleepiness Scale
Time Frame: week 4
It scores between 0 to 24, with higher scores meaning greater sleepiness.
week 4
the Patient Health Questionnaire 9-item version
Time Frame: week 4
It scores between 0 to 27, with higher scores meaning higher depressive symptoms.
week 4
the Generalized Anxiety Disorder 7-item version
Time Frame: week 4
It scores between 0 to 21, with higher scores meaning higher anxious symptoms.
week 4

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 12, 2021

Primary Completion (Actual)

June 12, 2021

Study Completion (Actual)

June 12, 2021

Study Registration Dates

First Submitted

June 8, 2022

First Submitted That Met QC Criteria

June 8, 2022

First Posted (Actual)

June 13, 2022

Study Record Updates

Last Update Posted (Actual)

June 16, 2022

Last Update Submitted That Met QC Criteria

June 13, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Primary Insomnia

Clinical Trials on Digital Cognitive Behavioral Therapy

Subscribe